Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice
Open Access
- 15 December 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (13) , 4391-4400
- https://doi.org/10.1182/blood.v100.13.4391
Abstract
The ability of advanced-generation lentiviral vectors to transfer the green fluorescent protein (GFP) gene into human hematopoietic stem cells (HSCs) was studied in culture conditions that allowed expansion of transplantable human HSCs. Following 96 hours' exposure to flt3/flk2 ligand (FL), thrombopoietin (TPO), stem cell factor (SCF), and interleukin-6 (IL-6) and overnight incubation with vector particles, cord blood (CB) CD34+ cells were further cultured for up to 4 weeks. CD34+ cell expansion was similar for both transduced and control cells. Transduction efficiency of nonobese diabetic/severe combined immunodeficient (NOD/SCID) repopulating cells (SRCs) was assessed by transplants into NOD/SCID mice. Mice that received transplants of transduced week 1 and week 4 expanded cells showed higher levels of human engraftment than mice receiving transplants of transduced nonexpanded cells (with transplants of 1 × 105 CD34+ cells, the percentages of CD45+ cells were 20.5 ± 4.5 [week 1, expanded] and 27.2 ± 8.2 [week 4, expanded] vs 11.7 ± 2.5 [nonexpanded]; n = 5). The GFP+/CD45+ cell fraction was similar in all cases (12.5% ± 2.9% and 12.2% ± 2.7% vs 12.7% ± 2.1%). Engraftment was multilineage, with GFP+/lineage+ cells. Clonality analysis performed on the bone marrow of mice receiving transduced and week 4 expanded cells suggested that more than one integrant likely contributed to the engraftment of GFP-expressing cells. Serial transplantations were performed with transduced week 4 expanded CB cells. Secondary engraftment levels were 10.7% ± 4.3% (n = 12); 19.7% ± 6.2% of human cells were GFP+. In tertiary transplants the percentage of CD45+ cells was lower (4.3% ± 1.7%; n = 10); 14.8% ± 5.9% of human cells were GFP+, and human engraftment was multilineage. These results show that lentiviral vectors efficiently transduce HSCs, which can undergo expansion and maintain proliferation and self-renewal ability.Keywords
This publication has 26 references indexed in Scilit:
- Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapyThe Journal of Gene Medicine, 2000
- Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequencesNature Genetics, 2000
- Stable transduction of quiescent CD34+CD38−human hematopoietic cells by HIV-1-based lentiviral vectorsProceedings of the National Academy of Sciences, 1999
- Lentiviruses as gene transfer agents for delivery to non-dividing cellsCurrent Opinion in Biotechnology, 1998
- Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo CultureThe Journal of Experimental Medicine, 1997
- Differential Maintenance of Primitive Human SCID-Repopulating Cells, Clonogenic Progenitors, and Long-Term Culture-Initiating Cells After Incubation on Human Bone Marrow Stromal CellsBlood, 1997
- Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapyNature Medicine, 1996
- Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocolsHuman Molecular Genetics, 1995
- Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID MiceScience, 1992
- Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.Proceedings of the National Academy of Sciences, 1990